Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Acetaminophen Label Guidance For Liver Warning Clarifies Ingredient Specifics

This article was originally published in The Tan Sheet

Executive Summary

FDA allows marketers of acetaminophen-containing OTC products to use an alternative liver warning, according to an updated guidance. The change from the draft, which aligns with a request by CHPA, separates maximum dosage for the ingredient from the dosage included in a certain product.

You may also be interested in...



High Acetaminophen Use In Pregnancy Linked To ADHD, Autism

Babies with cord blood biomarkers of acetaminophen on higher end of a scale are at three times risk of attention-deficit/hyperactivity disorder and almost four times at risk of autism spectrum disorder than babies with biomarkers on lower end, according to a JAMA study with 996 mother-infant pairs.

In Most Consumers' OTC Pain Relief Decisions, Safety Missing As A Factor

Most US consumers choose pain relievers based on speed and efficacy instead of factors critical to safe use – age, health conditions and use of other OTCs and drugs – according to a survey supported by J&J/McNeil.

In Most Consumers' OTC Pain Relief Decisions, Safety Missing As A Factor

Most US consumers choose pain relievers based on speed and efficacy instead of factors critical to safe use – age, health conditions and use of other OTCs and drugs – according to a survey supported by J&J/McNeil.

Related Content

Topics

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel